![](https://investorshub.advfn.com/uicon/659061.png?cb=1560643397)
Saturday, January 19, 2019 12:02:04 PM
Very risky move for investors, imho.
Do some research on the subject and historical outcomes of reverse splits. Pretty scary. Whatever this company has been doing thus far has not attracted new investors no matter how much good it has going for it. Still a lot of grey and unknowns. Still no evidence that Poda vape is an actual product, GTEC deal fell apart, lot's of management turnover, no updates on phase expansions, and Gene Simmons "issues".
As I have mentioned before, monitoring for the "right" buy-in point. If the company uplisting is approved and the RS brings the share value to say $7 CAD on Gene ticker and approximately $5 on IVITF the price could easily hit $3 CAD within a week or two of NASDAQ listing.
So my buy-in point would still be on target at pre-split assessment around the $0.50 (or less) CAD range.
Doesn't take "stones" to stay in a stock that is loosing value and is constantly putting their investors at significant risk.
Good luck to everyone on your investments and decisions.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM